Immune Therapeutics, Inc. (IMUN) Using the Power o
Post# of 39
Posted On: 03/10/2016 3:42:33 PM
Immune Therapeutics, Inc. (IMUN) Using the Power of the Body to Fight Cancer & AIDS
Cancer is the most serious disease in the history of mankind. All families in the U.S. and the world are affected by cancer either directly or indirectly. Men, women, and children of all races, creeds, and religions risk the possibility of being diagnosed with cancer – it does not discriminate. Some startling estimates for 2016 from the American Cancer Society are as follows: 841,390 new cancer cases in males in the U.S.; 843,820 new cancer cases in females in the U.S.; 314,290 deaths from cancer in males in the U.S.; and 281,400 deaths from cancer in females in the U.S.
Immune Therapeutics, Inc. (OTCQB: IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect people around the world. Building on the power of the body’s natural immune system, the company’s pipeline of products and immunotherapy technologies are designed to enhance the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.
Each year, cancer costs the world more money than any other disease, according to the American Institute of Cancer Research (AICR). Cancer costs $895 billion annually. Comparatively, heart disease costs $753 billion. Nothing else comes close, with traffic accidents and diabetes each costing about $204 billion. The biggest financial impact is in terms of loss of life and productivity, in which cancer accounts for 1.5 percent of global gross domestic product (GDP) losses.
Immunotherapy, also called biologic therapy, is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function.
Stimulating the body’s immune system remains one of the most promising approaches to addressing the unmet needs of cancers, HIV, inflammatory disease, autoimmune disease and other chronic infectious diseases. Immune Therapeutics’ immune therapy technology platform has shown the potential to establish a new paradigm to prevent and treat these life-altering diseases, with validating efficacy data from all phase I and phase II clinical trials for such diseases as HIV/AIDS, pancreatic cancer, Crohn’s Disease, liver disease, fibromyalgia and herpes.
Learn more by visiting www.immunetherapeutics.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Cancer is the most serious disease in the history of mankind. All families in the U.S. and the world are affected by cancer either directly or indirectly. Men, women, and children of all races, creeds, and religions risk the possibility of being diagnosed with cancer – it does not discriminate. Some startling estimates for 2016 from the American Cancer Society are as follows: 841,390 new cancer cases in males in the U.S.; 843,820 new cancer cases in females in the U.S.; 314,290 deaths from cancer in males in the U.S.; and 281,400 deaths from cancer in females in the U.S.
Immune Therapeutics, Inc. (OTCQB: IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect people around the world. Building on the power of the body’s natural immune system, the company’s pipeline of products and immunotherapy technologies are designed to enhance the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.
Each year, cancer costs the world more money than any other disease, according to the American Institute of Cancer Research (AICR). Cancer costs $895 billion annually. Comparatively, heart disease costs $753 billion. Nothing else comes close, with traffic accidents and diabetes each costing about $204 billion. The biggest financial impact is in terms of loss of life and productivity, in which cancer accounts for 1.5 percent of global gross domestic product (GDP) losses.
Immunotherapy, also called biologic therapy, is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function.
Stimulating the body’s immune system remains one of the most promising approaches to addressing the unmet needs of cancers, HIV, inflammatory disease, autoimmune disease and other chronic infectious diseases. Immune Therapeutics’ immune therapy technology platform has shown the potential to establish a new paradigm to prevent and treat these life-altering diseases, with validating efficacy data from all phase I and phase II clinical trials for such diseases as HIV/AIDS, pancreatic cancer, Crohn’s Disease, liver disease, fibromyalgia and herpes.
Learn more by visiting www.immunetherapeutics.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)Biostax Corp. (BTAX) Stock Research Links
Scroll down for more posts ▼